This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

R1 RCM Management

Management criteria checks 2/4

R1 RCM's CEO is Lee Rivas, appointed in Jan 2023, has a tenure of 1.83 years. total yearly compensation is $14.16M, comprised of 6.4% salary and 93.6% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth €1.46M. The average tenure of the management team and the board of directors is 3.3 years and 6.6 years respectively.

Key information

Lee Rivas

Chief executive officer

US$14.2m

Total compensation

CEO salary percentage	6.4%
CEO tenure	1.8yrs
CEO ownership	0.03%
Management average tenure	3.3yrs
Board average tenure	6.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Lee Rivas's remuneration changed compared to R1 RCM's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2024	n/a	n/a	-US$61m
Jun 30 2024	n/a	n/a	-US$40m
Mar 31 2024	n/a	n/a	-US$33m
Dec 31 2023	US$14m	US$900k	US$3m
Sep 30 2023	n/a	n/a	-US$35m
Jun 30 2023	n/a	n/a	-US$65m
Mar 31 2023	n/a	n/a	-US$91m
Dec 31 2022	US$4m	US$375k	-US$63m

Compensation vs Market: Lee's total compensation ($USD14.16M) is above average for companies of similar size in the German market ($USD3.50M).

Compensation vs Earnings: Lee's compensation has increased whilst the company is unprofitable.

CEO

Lee Rivas (49 yo)

1.8yrs

Tenure

US$14,159,376

Compensation

Mr. Lee Rivas served as President of R1 RCM Inc. since June 21, 2022 until December 31, 2022. He is Chief Executive Officer and Director at R1 RCM Inc. since January 01, 2023. Mr. Rivas joined R1 RCM Inc....

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Lee Rivas	CEO & Director	1.8yrs	US$14.16m	0.026% € 1.5m
John Sparby	President	1.8yrs	US$3.34m	0.062% € 3.5m
Jennifer Williams	Executive VP	1.8yrs	US$3.20m	0.0014% € 82.1k
Kyle Hicok	Executive VP & Chief Commercial Officer	1.8yrs	US$2.34m	0.0013% € 74.7k
Pamela Spikner	Principal Accounting Officer & Chief Accounting Officer	3.3yrs	no data	0.0063% € 361.1k
Brian Gambs	EVP & Chief Technology Officer	no data	no data	no data
Evan Smith	Senior Vice President of Finance & Investor Relations	1.2yrs	no data	no data
Corey Perman	Executive Vice President of Compliance & Risk	8.3yrs	no data	no data
Sean Radcliffe	Executive VP	7.8yrs	no data	no data
Kate Sanderson	Executive VP & Chief Human Resources Officer	6yrs	no data	no data
Logan Johnston	Executive Vice President of Performance Management	7.3yrs	no data	no data
David Strickle	Executive Vice President of Integration	6.8yrs	no data	no data

3.3yrs

Average Tenure

47yo

Average Age

Experienced Management: 6HL0's management team is considered experienced (3.3 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Lee Rivas	CEO & Director	1.8yrs	US$14.16m	0.026% € 1.5m
Neal Moszkowski	Independent Director	8.8yrs	no data	no data
John Henneman	Lead Independent Director	8.8yrs	US$320.02k	0.017% € 973.8k
Jill Smith	Independent Director	5.6yrs	US$275.00k	0.0095% € 543.1k
Anthony Tersigni	Director	5.3yrs	US$285.02k	0.013% € 725.6k
Anthony Speranzo	Chairman of the Board	8.8yrs	US$400.01k	0.013% € 769.6k
David Dill	Director	3.6yrs	US$285.01k	0.0065% € 368.5k
Agnes Bundy Scanlan	Independent Director	3.3yrs	US$278.77k	0.0041% € 234.5k
Ian Sacks	Independent Director	8.8yrs	no data	no data
Joseph Flanagan	Director	8.5yrs	US$207.18k	0.80% € 45.5m
Michael Feiner	Independent Director	7.7yrs	US$265.02k	0.011% € 613.3k
Bradford Armbrester	Independent Director	2.4yrs	US$265.02k	0.0027% € 152.9k

6.6yrs

Average Tenure

60yo

Average Age

Experienced Board: 6HL0's board of directors are considered experienced (6.6 years average tenure).

This company listing is no longer active

R1 RCM Management

Management criteria checks 2/4

Key information

Recent management updates

R1 RCM Inc., Annual General Meeting, May 22, 2024

R1 RCM Inc. Appoints Pamela L. Spikner as Principal Accounting Officer

R1 RCM Inc. Appoints Clay Ashdown as Director

R1 RCM Inc. Announces Janie Wade Resigns from its Board of Directors

Senior VP recently sold €452k worth of stock

President recently sold €298k worth of stock

Recent updates

R1 RCM Inc.(NasdaqGM:RCM) dropped from NASDAQ Composite Index

R1 RCM Inc.(NasdaqGS:RCM) dropped from S&P Health Care Services Select Industry Index

Third quarter 2024 earnings released: US$0.047 loss per share (vs US$0.003 profit in 3Q 2023)

R1 RCM Inc. Provides Unaudited Preliminary Financial Guidance for the Fiscal Quarter Ended September 30, 2024

Second quarter 2024 earnings released: US$0.018 loss per share (vs US$0.002 loss in 2Q 2023)

TowerBrook Capital Partners L.P. and Clayton, Dubilier & Rice, LLC agreed to acquire remaining 64% stake in R1 RCM Inc. (NasdaqGS:RCM) from TowerBrook Capital Partners L.P. and others for $6.3 billion.

R1 RCM Inc. to Report Q2, 2024 Results on Aug 07, 2024

R1 RCM Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings released: US$0.083 loss per share (vs US$0.004 profit in 1Q 2023)

R1 RCM Inc., Annual General Meeting, May 22, 2024

R1 RCM Inc. to Report Q1, 2024 Results on May 08, 2024

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2024

New minor risk - Earnings quality

New Mountain Partners V (AIV-D), L.P. and New Mountain Investments V, L.L.C., managed by New Mountain Capital, L.L.C. submits a non-binding proposal to acquire remaining 67.56906% stake in R1 RCM Inc. (NasdaqGS:RCM) from TowerBrook Investors, Ltd and others for approximately $4 billion.

Full year 2023 earnings released: EPS: US$0.008 (vs US$0.18 loss in FY 2022)

Coliseum Capital Issues an Open Letter to the Board of R1 RCM

R1 RCM Inc. Appoints Pamela L. Spikner as Principal Accounting Officer

R1 RCM Inc. (NasdaqGS:RCM) completed the acquisition of Acclara Solutions, LLC from Providence St. Joseph Health for $680 million.

R1 RCM Inc. to Report Q4, 2023 Results on Feb 27, 2024

R1 RCM Inc. Appoints Clay Ashdown as Director

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Inc. (NasdaqGS:RCM) entered into the Purchase Agreement to acquire Acclara Solutions, LLC from Providence St. Joseph Health.

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Receives Notice Of Filing Delinquency from Nasdaq

R1 RCM Inc. announced delayed 10-Q filing

R1 RCM Inc. Provides Revenue Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.003 (vs US$0.071 loss in 3Q 2022)

R1 RCM Inc. Announces Janie Wade Resigns from its Board of Directors

New minor risk - Share price stability

R1 RCM Inc. to Report Q3, 2023 Results on Nov 02, 2023

Now 21% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: US$0.001 (vs US$0.069 loss in 2Q 2022)

R1 RCM Inc. Provides Earnings Guidance for the Year of 2023

R1 RCM Inc. to Report Q2, 2023 Results on Aug 02, 2023

Senior VP recently sold €452k worth of stock

President recently sold €298k worth of stock

R1 RCM Inc. Provides Earnings Guidance for the Year 2023

First quarter 2023 earnings released: EPS: US$0.001 (vs US$0.10 in 1Q 2022)

CEO & Director recently bought €937k worth of stock

Full year 2022 earnings released: US$0.16 loss per share (vs US$1.86 loss in FY 2021)

R1 RCM Inc. Provides Earnings Guidance for the Fiscal Year 2023

R1 RCM Inc. to Report Q4, 2022 Results on Feb 16, 2023

R1 RCM Inc. Announces Chief Financial Officer Changes

R1 RCM Inc. Appoints Janie Wade as a Director of the Company, Effective January 1, 2023

R1 RCM Inc. Announces Retirement of Albert Zimmerli from the Board of Directors, Effective January 1, 2023

Third quarter 2022 earnings released: US$0.071 loss per share (vs US$0.061 profit in 3Q 2021)

R1 RCM Inc. Provides Earnings Guidance for the Year 2022

R1 RCM Inc. to Report Q3, 2022 Results on Nov 08, 2022

Key Executive recently sold €996k worth of stock

R1 RCM Inc. Appoints Brian Dean as Director

Independent Director recently sold €266k worth of stock

Second quarter 2022 earnings released: US$0.069 loss per share (vs US$0.069 profit in 2Q 2021)

R1 RCM Inc. Provides Revenue Guidance for the Full Year of 2022

R1 RCM Inc. to Report Q2, 2022 Results on Aug 03, 2022

New Mountain Capital Engages in Discussions with R1 RCM Inc

R1 RCM Inc. Revises Revenue Guidance for the Year 2022

R1 RCM Inc. Announces Committee Changes

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age